Dr. Daniel Blumberger is the scientific director of the Temerty Centre for Therapeutic Brain Intervention, co-chief of General Adult Psychiatry and Health Systems, and a senior scientist at the Centre for Addiction and Mental Health (CAMH). He additionally holds the Temerty Chair in Therapeutic Brain Intervention at CAMH.
Dr. Blumberger is a subspecialist in geriatric psychiatry and a professor in the Department of Psychiatry in the Temerty Faculty of Medicine at the University of Toronto and a full member of the Institute of Medical Sciences.
He received his MD and completed residency training in psychiatry at the University of Toronto. After completing his residency training, he completed a MSc in neuroscience through the Institute of Medical Sciences and completed a fellowship in brain stimulation and geriatric psychiatry funded by the Canadian Institute of Health Research and received a NARSAD young investigator award from the Brain and Behavior Research Foundation.
Areas of Research
Dr. Blumberger’s research focuses on the use of interventional psychiatry approaches with a focus on brain stimulation therapies for refractory psychiatric disorders. His main research focuses on clinical intervention trials of novel treatments and understanding the neurobiology of treatment-resistant depression across the lifespan. His research has been funded by the Canadian Institutes of Health Research, National Institute of Mental Health (US), Brain Canada, Weston Brain Institute, Brain and Behavior Research Foundation, and Patient- Centered Outcomes Research Institute.
He is the principal investigator or co-investigator on multiple clinical trials using different brain stimulation modalities and novel drug approaches including: electroconvulsive therapy (ECT), ketamine, magnetic seizure therapy (MST), psilocybin, repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS).
View Dr. Blumberger’s publications on PubMed.